Biotech

All Articles

Former Seagen chief executive officer reveals brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2014 for a whoppin...

Ironwood makes additional bid for $1B GI medicine along with brand-new subgroup information

.On the heels of a phase 3 win that failed to make an impression on financiers, Ironwood Pharmaceuti...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Don't stop Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a ha...

Jade carves out exec crew along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shootin...

Septerna goes public with upsized offering of $288M

.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...

AbbVie creates Richter wealthier, paying out $25M to form finding treaty

.AbbVie has come back to the source of its own antipsychotic giant Vraylar looking for yet another r...

GenSight enters last full weeks of cash money runway as profits stream noses out of reach

.GenSight Biologics is actually full weeks away from losing loan. Again. The biotech simply has enou...

AZ licenses disposed of rare health condition medicine to Monopar Therapeutics

.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's unusual diseas...

Arcus' brand-new HIF-2a data in renal cancer cells mention prospective edge over Merck's Welireg, professionals mention

.Along with new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of ana...

Roche wagers around $1B to increase Dyno genetics therapy delivery deal

.After forming a gene treatment alliance along with Dyno Therapies in 2020, Roche is back for even m...